Patients

  1. Cristina's story

    "I heard by chance about a new clinical trial for migraine (for the substance that would become Aimovig) on the radio and the doctor encouraged patients to write to him to see if they were eligible candidates. So I did write and they accepted me for the trial. This trial was going to be 18 months long."

    Read more »
  2. 10 important facts to know about the new migraine injection

    You might have heard about a new medicine that’s just been approved to treat migraine. Here’s what you need to know.

    Glasses

    Read more »
  3. Michel's story

    Michel has chronic migraine and shares his experiences seeking a treatment that works and his advice for other migraineurs. Image: stock - Michel wishes to remain anonymous.  

    Read more »
  4. What is Tudca?

    News update5 common questions about the supplement that may be useful for ALS, Parkinson's and Alzheimers.

    Read more »
  5. What is ‘cold chain’ delivery?

    Find out about what it means to order and receive temperature-controlled medicines.

    Map

    Read more »
  6. How does Alecensa (alectinib) work for ALK+ NSCLC?

    Line up of people (stock)An easy to understand guide on how alectinib works.

    Read more »
  7. What’s after platinum-based chemo? Niraparib as a maintenance treatment for ovarian, fallopian tube, or primary peritoneal cancer

    Dandelion (conceptual)A closer look at the function and efficicacy of niraparib as a maintenace treatment.

    Read more »
  8. Abdur’s story


    Abdur was diagnosed with ALS in 2016. His uncle, Jamashaid, shares his story and how Radicut (edaravone) has helped Abdur to live better with ALS.

    Read more »
  9. News for metastatic melanoma patients

    There are a number of medicines available for melanoma patients. In this article we examine one newer medicine and discuss it's efficacy and use. 

    Elderly couple cooking together 

    Read more »
  10. Why is niraparib (Zejula) important for women with recurrent ovarian cancer?

    The European Medicines Agency has recently approved Niraparib (Zejula) for use in the European Union as a treatment for women struggling with a specific type of advanced ovarian cancer known as high-grade serous epithelial ovarian cancer, which includes cancers that affect the peritoneum and/or the fallopian tubes.

    smiling woman with friends 

    Read more »
  11. What’s the difference between a brand name and a generic medicine?

    brand name generic medicine
    When a new medicine gets approved for use and for sale in a specific region, it’s usually given a brand name by the pharmaceutical company who discovered or developed it.

    Read more »
  12. Francine's story


    My father, who was a general practitioner before he retired, was with me when we heard the official report of the neurologist. Afterwards, sitting in the car, he had to digest the fact that both his son and daughter had multiple sclerosis.

    Read more »